Fundraising Fox
Ampriondx
San Francisco, US · Founded 2007 · Delaware corporation · 37 employees on LinkedIn · 1 known investors
Find your way into Ampriondx
Each arrow is one introduction. Sign up to fill in the first one.
Ask Martin Brown to introduce you to Russ Lebovitz
You →Martin · together at Ambra BioScience →Russ
Sign up to find every way you can get introduced to Ampriondx
- Your email: who you already know at Ampriondx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ampriondx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.
Founders & leadership
Ampriondx was founded in 2007 by Russell Lebovitz and Claudio Soto.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.7M disclosed across 2 rounds · 2022–2024
▶$5.8MraisedSep 2024 · 7 investors · BiotechnologyRule 506(b)
- Marc ChanDirector
- Russell LebovitzExecutive Officer, Director
- Rahul BhansaliDirector
- Offering amount
- $15M
- Amount sold
- $5.8M
- Proceeds to insiders
- $291.5K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJul 2022 · 9 investors · BiotechnologyRule 506(b)
- Claudio SotoDirector
- Marc ChanDirector
- Peter ClintonDirector
- Kenneth LehmanDirector
- Russell LebovitzExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- Proceeds to insiders
- $550K
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Ampriondx.
Frequently asked questions
- What does Ampriondx do?
- Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.
- Who founded Ampriondx?
- Ampriondx was founded by Russell Lebovitz, Claudio Soto in 2007.
- Who are Ampriondx's investors?
- Ampriondx's investors include Snatched Ventures.
- How much funding has Ampriondx raised?
- Ampriondx has disclosed $16.7M raised across 2 rounds.
- Where is Ampriondx headquartered?
- Ampriondx is headquartered in San Francisco, US.